PP
ARNA

Paloma Partners’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Paloma Partners’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-6,264
Closed -$394K – 2641
2020
Q2 		$394K Buy
+6,264
New +$345K 0.01% 1340
2020
Q1 		– Sell
-11,817
Closed -$537K – 2303
2019
Q4 		$537K Buy
+11,817
New +$559K 0.01% 1362
2019
Q1 		– Sell
-6,016
Closed -$235K – 2040
2018
Q4 		$235K Buy
+6,016
New +$236K 0.01% 974
2015
Q3 		– Sell
-2,890
Closed -$134K – 2038
2015
Q2 		$134K Buy
+2,890
New +$125K ﹤0.01% 1641
2015
Q1 		– Sell
-2,865
Closed -$99K – 1498
2014
Q4 		$99K Buy
+2,865
New +$116K ﹤0.01% 1070

Other funds holding ARNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Paloma Partners's ARNA Position: Q3 2020 in Review

Paloma Partners sold out of Arena Pharmaceuticals Inc (ARNA) in Q3 2020, closing a stake of 6,264 shares — an estimated $394K sold.

Paloma Partners first reported a position in ARNA in Q4 2014 and held it in 5 quarters. The position peaked at $537K in Q4 2019. 253 funds tracked by Wall St. Rank hold ARNA as of Q3 2020.

  • Paloma Partners reported no remaining Arena Pharmaceuticals Inc position as of Q3 2020 after selling out during the quarter.
  • Paloma Partners sold 6,264 Arena Pharmaceuticals Inc shares in Q3 2020, an estimated $394K.
  • Paloma Partners first reported a position in Arena Pharmaceuticals Inc in Q4 2014 and held it in 5 quarters.
  • Paloma Partners's Arena Pharmaceuticals Inc position peaked at $537K in Q4 2019.
  • 253 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2020.

Based on Paloma Partners's 13F filing for Q3 2020, filed 16 Nov 2020.